MedTrace Logo

Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease

NCT02986516 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-01-02

No results posted yet for this study

Summary

Comparative study on surgery versus definitive radiation therapy in primary localized sacral chordoma

Conditions

  • Chordoma

Interventions

OTHER

Randomized Cohort

Surgical treatment with different approach, based on the characteristics of the tumor or definitive high dose radiotherapy (carbon ion radiotherapy, proton-therapy, mixed photons-proton therapy) will be assigned by randomization

RADIATION

Prospective cohort

Surgical treatment or definitive high dose radiotherapy will be selected by the patients and will be prospectively evaluated

Sponsors & Collaborators

  • Italian Sarcoma Group

    lead NETWORK

Principal Investigators

  • Alessandro Gronchi, MD · Istituto Nazionale Tumori Milan-Italy

  • Piero Fossati, MD · MedAustron Graz-Austria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-16
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Austria
  • Germany
  • Hungary
  • Italy
  • Japan
  • Netherlands
  • Norway
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02986516 on ClinicalTrials.gov